Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic? by Merve Keskinkilic, Merve Keskinkilic, Huseyin Salih Semiz, Tugba Yavuzsen, Ilhan Oztop

Get full text

The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-e... by Merve Keskinkilic, Mehmet Emin Arayici, Yasemin Basbinar, Hulya Ellidokuz, Tugba Yavuzsen, Ilhan Oztop

Get full text

lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma by Burcin PEHLIVANOGLU, Anil AYSAL, Cihan AGALAR, Tufan EGELI, Mucahit OZBILGIN, Tarkan UNEK, Ilkay Tugba UNEK, Ilhan OZTOP, Safiye AKTAS, Ozgul SAGOL

Get full text

Inflammation-Associated Long Non-Coding RNAs (lncRNAs) in Chronic Viral Hepatitis- Associated Hepatocellular Carcinoma by Burcin PEHLIVANOGLU, Anil AYSAL, Cihan AGALAR, Tufan EGELI, Mucahit OZBILGIN, Tarkan UNEK, Ilkay Tugba UNEK, Ilhan OZTOP, Safiye AKTAS, Ozgul SAGOL

Get full text